Apolipoprotein E genotype in matched men and women with coronary heart disease

Annals of Clinical and Laboratory Science

Volumn 35, Issue 4, 2005, Pages 391-396

  Kolovou, Genovefa D ^a   Anagnostopoulou, Katherine K ^a   Salpea, Klelia D ^a   Panagiotakos, Demosthenes B ^b   Hoursalas, Ioannis S ^a   Cariolou, Marios A ^c   Koniavitou, Katerina ^a   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Apolipoprotein E; Coronary heart disease; Polymorphism; Risk stratification

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; FEMALE; GENOTYPE; GREECE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; APOLIPOPROTEINS E; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; MALE; POLYMORPHISM, GENETIC; POSTMENOPAUSE; SEX FACTORS;

EID: 27644528189     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. American Heart Association. Heart and Stroke Facts Statistics: 1996 Statistical Supplement. American Heart Association, Dallas, Texas, 1996.
2. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
3. Lloyd-Jones DM, Wilson PW, Larson MG, Leip E, Beiser A, D'Agostino RB, Cleeman JI, Levy D. Lifetime risk of coronary heart disease by cholesterol levels at selected ages. Arch Intern Med 2003;163:1966-1972.
4. Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vase Biol 1996;16: 1250-1255.
5. Damaraju S, Yu QT, Safavi F, Marian AJ. Apolipoprotein epsilon 4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;75:1181-1183.
6. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002;155:487-495.
7. Kolovou G, Yiannakouris N, Hatzivassiliou M, Malakos J, Daskalova D, Hatzigeorgiou G, Cariolou M, Cokkinos DV. Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease. Cur Med Res Opin 2002;18:118-124.
8. Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, Osgood D, Parpos S, Pedro-Botet J, Daly JA, Ordovas JM. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001;154:529-537.
9. Scuteri A, Bos AJ, Zonderman AB, Brant LJ, Lakatta EG, Fleg JL. Is the apoE4 allele an independent predictor of coronary events? Am J Med 2001;110:28-32.
10. Frikke-Schmidt R, Tybjaerg-Hansen A, Steffensen R, Jensen G, Nordestgaard BG. Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon-44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 2000;35:1192-1199.
11. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994;272:1666-1671.
12. Ilveskoski E, Jarvinen O, Sisto T, Karhunen PJ, Laippala P, Lehtimaki T. Apolipoprotein E polymorphism and atherosclerosis: association of the epsilon-4 allele with defects in the internal elastic lamina. Atherosclerosis 2000;153:155-160.
13. Hoffmann MM, Scharnagl H, Koster W, Winkler K, Wieland H, Marz W. Apolipoprotein E1 Baden (Arg(180)→Cys). A new apolipoprotein E variant associated with hypertriglyceridemia. Clin Chim Acta 2001; 303:41-48.
14. Oh JY, Barrett-Connor E. Apolipoprocein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study. Clin Genet 2001; 60:132-137.
15. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981;63:285-299.
16. Rail SC Jr, Weisgraber KH, Mahley RW. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 1982;257:4171-4178.
17. Das HK, McPherson J, Bruns GA, Karathanasis SK, Breslow JL. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985;260:6240-6247.
18. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
19. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 1977;269:604-607.
20. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-235.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 1972;18:499-502.
22. Kataoka S, Robbins DC, Cowan LD, Go O, Yeh JL, Devereux RB, Fabsitz RR, Lee ET, Welty TK, Howard BV. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. Arterioscler Thromb Vase Biol 1996;16:918-925.
23. Asakawa J, Takahashi N, Rosenblum BB, Neel JV. Two-dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet 1985;70:222-230.
24. Tsuchiya S, Yamanouchi Y, Onuki M, Yamakawa K, Miyazaki R, Taya T, Kondo I, Ohnuki M, Hamaguchi H. Frequencies of apolipoproteins E5 and E7 in apparently healthy Japanese. Jinrui Idengaku Zasshi 1985; 30:271-278.
25. Eto M, Watanabe K, Ishii K. A racial difference in apolipoprotein E allele frequencies between Japanese and Caucasian populations. Clin Genet 1986;30:422-427.
26. Evans AE, Zhang W, Moreel JF, Bard JM, Ricard S, Poirier O, Tiret L, Fruchart JC, Cambien F. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men. Hum Genet 1993;92:191-197.
27. Bailleul S, Couderc R, Landais, Lefevre G, Raichvarg D, Etienne J. V. Direct phenotyping of human apolipoprotein E in plasma: Application to population frequency distribution in Paris (France). Hum Hered 1993;43:159-165.
28. James RW, Boemi MG, Giansanti R, Fumelli P, Pometta D. Under-expression of the apolipoprotein E4 isoform in an Italian population. Arterioscler Thromb 1993;13:1456-1459.
29. Kolovou G, Daskalova D, Hatzivassiliou M, Yiannakouris N, Pilatis N, Elisaf M, Mikhailidis D, Cariolou M, Cokkinos D. The epsilon 2 and 4 alleles of apolipoprotein E and ischemic vascular events in the Greek population- Implications for the interpretation of similar studies. Angiology 2003;54:51-58.
30. Eggertsen G, Tegelman R, Ericsson S, Ericsson S, Angelin B, Berglund: Apolipoprotein E polymorphism in a healthy Swedish population. Variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993;39:2125-2129.
31. Dallongeville J. Apolipoprotein E: propriétés physiologiques, polymorphisme et atherosclerose. Sang Thrombose Vaisseaux 1993;5:707-717.
32. Kolovou G, Daskalova D, Mikhailidis DP. Apolipoprotein E polymorphism and atherosclerosis. Angiology 2003;54:59-71.
33. Keavney B, Palmer A, Parish S, Clark S, Youngman L, Danesh J, McKenzie C, Delepine M, Lathrop M, Peto R, Collins R; International Studies of Infarct Survival (ISIS) Collaborators. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol. 2004;33:1002-1013.
34. Garry PJ, Baumgartner RN, Brodie SG, Montoya GD, Liang HC, Lindeman RD, Williams TM. Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene. Clin Chem 1999;45:1214-1223.
35. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987;114:1467-1503.
36. Modan M, Or J, Karasik A, Drory Y, Fuchs Z, Lusky A, Chetrit A, Halkin H. Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation 1991; 84:1165-1175.
37. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-1162.
38. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T, Yokota M. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 2003;42:1429-1437.
39. van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-880.